Minitablets

Minitablets: Enhancing Safety and Palatability for Pediatric Medicines

Gus LaBella

Mikart

Developability

Assessing Developability and Designing Advanceable Formulations from the Start

Nazar Elkarim, Ph.D.

Mikart

Liquid Suspensions

Beyond Pills: the Rise of Liquid Suspensions for Complex Formulations

Gus LaBella

Mikart

Digitalization

How can Life Science Technology Providers Support the Pharmaceutical Industry in the Transition Toward More Digitally Connected Operations?

Pharma's Almanac

Investment

What are the Current Investment Trends in the Pharmaceutical Industry, and How are They Influencing the Sector’s Direction?

Pharma's Almanac

Commitment to ESG Principles

How can pharmaceutical and biopharmaceutical companies demonstrate their commitment to ESG principles in manufacturing?

Pharma's Almanac

Accelerating Product Development

What strategies are being employed to accelerate product development and commercialization without compromising quality?

Pharma's Almanac

Chromatography

Navigating HPLC Method Development: Tips for Success

Ransom Jones

Mikart

Failing Fast

Maximizing Resources and Potential for Success by Failing Fast

Nazar Elkarim, Ph.D.

Mikart

Formulation

Addressing Swallowing and Palatability Issues with Patient-Friendly Dosage Forms

Gus LaBella

Mikart

Industry Wisdom

What Piece of Conventional Industry Wisdom Do You Think is Misguided, Outdated, or Just Plain Wrong?

Pharma's Almanac

Roundtable: Artificial Intelligence

In what areas of pharma/biopharma are you most excited to see increased adoption of artificial intelligence (AI) and machine learning?

Pharma's Almanac

Roundtable: Patient Centricity

How is an increased focus on patient-centric concerns influencing the way that you work?

Pharma's Almanac

Expanded CDMO Capabilities

On the Journey to Support Drug Developers With End-to-End Outsourcing

Michelle Hall

Mikart

OSD and Liquid

Reshoring Manufacturing and Targeted, Specialty Medicines

Mikart